NSC31205 is primarily utilized in research settings for its potential as an anticancer agent. It has been studied for its ability to inhibit certain enzymes or pathways involved in cancer cell proliferation, making it a candidate for further development in chemotherapy. Researchers are exploring its efficacy in targeting specific types of tumors, particularly in preclinical models. Additionally, its mechanism of action is being investigated to understand its potential in overcoming drug resistance in cancer treatment. While not yet approved for clinical use, NSC31205 represents a promising compound in the ongoing search for novel cancer therapies.